SatioRx™
Drug & Vaccine Delivery
SatioRx technology provides a convenient and comfortable drug delivery experience based on
- an Adhesive Patch-based Platform
- which utilizes a Reusable Applicator for both functionality and sustainability
Disposable handheld autoinjectors for at-home use were an important advance 20+ years ago, but:
- As Chronic Diseases with frequently dosed drugs grow and
- As Biologics exceed autoinjectors’ ability to avoid pain and incomplete injections,
The opportunity and the need for change are clear.
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.
Pain Points
Why are Drug and Compliance rates so low?
- 2 in 3 children and 1 in 4 adults have strong fears around needles.
- With autoinjectors, an increase in the volume of a drug usually means an increase in the amount of fluid injected per second – causing more pain and often, an incomplete dose aka a ‘wet injection.’
- The body’s own first line of defense for disease – the intradermal layer of the skin – is potentially the most effective place to deliver a medicine. However, no one has developed a way to deliver intradermally at home, precisely and the same way every time by anyone – to automate its delivery.
SatioRx™ intradermal automation targets three key Drivers of Drug Development
- Getting biologics to their targets
- Getting a Therapeutic Dose (including 1mL or more)
- Simple and Consistent Delivery – administered at home
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.
- Better Access
- Improved Workflow
- Low Cost
- Faster Clinical Decisions
SatioRx™ Drug Delivery Patch WorkFlow
SatioRx platform is designed to improve delivery experience for patients and expand options for drug developers and healthcare providers
- Stable Patch and Motor Controlled Delivery
- Optimal Pace
- Wide range of volumes and viscosities
- Connected functionality enabled such as
- go/no-go sensors
- biometrics integration
- telehealth portal
- remote activation
- information flow with patient, providers, payors
- Subcutaneous and Intradermal route of administration
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.
SatioRx™ partners
The Institut Pasteur is an internationally renowned center for biomedical research that stands out in many disciplines.
MedInstill / INTACT Solutions provide INTACT™ technologies to deliver innovative sterile liquid filling, multiple-dose dispensing, transfer and packaging solutions to achieve consistent sterile results.
Partner with SatioRx™
Satio is partnering with pharmaceutical and vaccine companies to enable at home or remote drug delivery for Multiple Use Cases:
- Intradermal Drug Delivery
- Better injection experience, adherence and sustainability
- for repeat injections
- for high volume/concentration drugs, with algorithmic delivery as needed
- Telehealth and Biometric integration
- Shift in Site of Care
"*" indicates required fields
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.